Published in Cell on November 01, 1974
Characterization of Rous sarcoma virus src gene products synthesized in vitro. J Virol (1978) 6.39
Comparison of the expression of the src gene of Rous sarcoma virus in vitro and in vivo. J Virol (1978) 5.30
Distinguishable transformation-defective phenotypes among temperature-sensitive mutants of Rous sarcoma virus. J Virol (1977) 1.79
Polymorphism of avian sarcoma virus src proteins. J Virol (1979) 1.47
A prospective randomized study of the potential benefits of thoracic epidural anesthesia and analgesia in patients undergoing coronary artery bypass grafting. Anesth Analg (2001) 4.48
Analysis of the ribonucleic acid of murine leukemia virus. J Virol (1969) 4.32
A soluble CD4 protein selectively inhibits HIV replication and syncytium formation. Nature (1988) 4.15
Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med (1989) 3.03
Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS. Science (1995) 2.16
Thoracic epidural anaesthesia for coronary artery bypass graft surgery. Effects on postoperative complications. Anaesthesia (1997) 2.04
Temperature-dependent transformation of cells infected with a mutant of Bryan Rous sarcoma virus. J Virol (1972) 2.01
Viral ribonucleic acid polymerase: chick-embryo cells infected with vesicular stomatitis virus or Rous-associated virus. Biochim Biophys Acta (1965) 1.71
Conservation of heterochromatin protein 1 function. Mol Cell Biol (2000) 1.70
Metabolic requirements for infection by Rous sarcoma virus. I. The transient requirement for DNA synthesis. Virology (1966) 1.69
Monitoring women at risk for preterm labor. N Engl J Med (1998) 1.68
Electron microscopic observations on the ribonucleic acid of murine leukemia virus. J Virol (1969) 1.67
Inhibitors of glycosylation reverse retroviral interference. Virology (1982) 1.64
Control of acute Zollinger-Ellison syndrome with intravenous omeprazole. Lancet (1982) 1.63
Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2. Mol Cell (2001) 1.59
Studies on the fixation and development of cellular transformation by Rous sarcoma virus. Virology (1968) 1.57
Molecular cloning and expression of T11 cDNAs reveal a receptor-like structure on human T lymphocytes. Proc Natl Acad Sci U S A (1987) 1.49
Induction of mutations in an RNA tumour virus by an analogue of a DNA precursor. Nat New Biol (1971) 1.46
A change in growth potential of cells after conversion by Rous sarcoma virus. J Cell Physiol (1967) 1.45
The structure of CDK4/cyclin D3 has implications for models of CDK activation. Proc Natl Acad Sci U S A (2009) 1.45
Human population genetic structure and diversity inferred from polymorphic L1(LINE-1) and Alu insertions. Hum Hered (2006) 1.44
Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type II integral membrane protein. Proc Natl Acad Sci U S A (1988) 1.41
Importation and use of medicines by farmers. Vet Rec (1999) 1.39
Strategies for estimating behavioural frequency in survey interviews. Memory (1998) 1.36
Characteristics of cores of avian leuko-sarcoma viruses. Virology (1970) 1.36
Production of virus by mammalian cells tranformed by Rous sarcoma and murine sarcoma viruses. J Virol (1968) 1.34
The cyclin box fold: protein recognition in cell-cycle and transcription control. Trends Biochem Sci (1997) 1.34
Synthesis of the RNA of RNA-containing tumor viruses. I. The interval between synthesis and envelopment. Virology (1970) 1.29
Transformation by murine sarcoma virus: fixation (deoxyribonucleic acid synthesis) and development. J Virol (1968) 1.28
Problem severity model and implementation plan for occupational health and safety: a case study of Allegheny County, Pennsylvania. Am Ind Hyg Assoc J (1972) 1.26
The safety profile of De-Nol. Digestion (1987) 1.26
Glycolysis in chick embryo cell cultures transformed by Rous sarcoma virus. Cancer Res (1968) 1.17
Binding site for human immunodeficiency virus coat protein gp120 is located in the NH2-terminal region of T4 (CD4) and requires the intact variable-region-like domain. Proc Natl Acad Sci U S A (1988) 1.17
Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2. Nat Struct Biol (1997) 1.16
Adenosylhomocysteine hydrolase inhibitors: synthesis of 5'-deoxy-5'-(isobutylthio)-3-deazaadenosine and its effect on Rous sarcoma virus and Gross murine leukemia virus. Biochem Biophys Res Commun (1978) 1.15
Efficacy, pharmacokinetics, and in vivo antiviral activity of UC781, a highly potent, orally bioavailable nonnucleoside reverse transcriptase inhibitor of HIV type 1. AIDS Res Hum Retroviruses (1997) 1.12
The uptake of nucleosides by cells in culture. I. Inhibition by heterologous nucleosides. Biochim Biophys Acta (1969) 1.04
3-Deazaadenosine, an inhibitor of adenosylhomocysteine hydrolase, inhibits reproduction of Rous sarcoma virus and transformation of chick embryo cells. Virology (1978) 1.03
Discovery and in vitro development of AIDS antiviral drugs as biopharmaceuticals. Adv Pharmacol (1995) 1.02
Identity by descent and DNA sequence variation of human SINE and LINE elements. Cytogenet Genome Res (2005) 1.00
Quantitation of intracellular membrane-bound enzymes and receptors in digitonin-permeabilized cells. Anal Biochem (1983) 1.00
Metabolic requirements for infection by Rous sarcoma virus. 3. The synthesis on viral DNA. Virology (1972) 0.98
Inhibition of multiple phases of human immunodeficiency virus type 1 replication by a dithiane compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteins. Antimicrob Agents Chemother (1997) 0.97
Biological and biochemical anti-HIV activity of the benzothiadiazine class of nonnucleoside reverse transcriptase inhibitors. Antiviral Res (1994) 0.97
Electrophoretic determinations of hyaluronate produced by cells in culture. Biochim Biophys Acta (1972) 0.97
Investigation of the structural basis of the interaction of calpain II with phospholipid and with carbohydrate. Biochem J (1990) 0.96
Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein. Nat Med (1997) 0.96
Studies of the active site of m-calpain and the interaction with calpastatin. Biochem J (1993) 0.95
Studies on the relationship between glycolysis and (Na+ + K+)-ATPase in cultured cells. Biochim Biophys Acta (1984) 0.95
Configurational variants of oncornavirus RNAs. J Virol (1976) 0.94
Forward telescoping: the question matters. Memory (1998) 0.94
Screening of colorectal cancer. Dig Dis Sci (1986) 0.94
Prevention of preterm birth in high-risk patients: the role of education and provider contact versus home uterine monitoring. Am J Obstet Gynecol (1991) 0.94
Acute spontaneously recovering ulcerating colitis (ARUC). Report of 6 cases. Am J Dig Dis (1977) 0.93
Acute gastroduodenal lesions related to severe sepsis. Surg Gynecol Obstet (1976) 0.93
A new class of anti-HIV-1 agents targeted toward the nucleocapsid protein NCp7: the 2,2'-dithiobisbenzamides. Bioorg Med Chem (1997) 0.93
Metabolic requirements for infection by Rous sarcoma virus. IV. Virus reproduction and cellular transformation without cellular division. Virology (1972) 0.93
[Efficacy of ranitidine and cimetidine in the treatment of gastric or duodenal ulcer resistant to an initial treatment with cimetidine. Multicenter controlled therapeutic trial]. Gastroenterol Clin Biol (1985) 0.92
The structure of the RNA of RNA-containing tumor viruses. Curr Top Microbiol Immunol (1970) 0.89
Biological and biochemical anti-human immunodeficiency virus activity of UC 38, a new non-nucleoside reverse transcriptase inhibitor. J Pharmacol Exp Ther (1996) 0.89
Unique anti-human immunodeficiency virus activities of the nonnucleoside reverse transcriptase inhibitors calanolide A, costatolide, and dihydrocostatolide. Antimicrob Agents Chemother (1999) 0.89
[Comparative efficacy of omeprazole and cimetidine in the treatment of duodenal ulcer in the acute stage. A French multicenter, controlled therapeutic trial]. Gastroenterol Clin Biol (1987) 0.88
[Treatment of duodenal and gastric ulcer with cimetidine. A multicenter double-blind trial (author's transl)]. Gastroenterol Clin Biol (1977) 0.88
Design, synthesis, and biological evaluation of cosalane, a novel anti-HIV agent which inhibits multiple features of virus reproduction. J Med Chem (1994) 0.88
Novel sulfonated and phosphonated analogs of distamycin which inhibit the replication of HIV. Antiviral Res (1995) 0.87
Adhesion domain of human T11 (CD2) is encoded by a single exon. Proc Natl Acad Sci U S A (1988) 0.87
[Histological and cytological study of the tumoral and nontumoral endocrine pancreas in the Zollinger-Ellison syndrome]. Rev Int Hepatol (1966) 0.87
The uptake of nucleosides by cells in culture. II. Inhibition by 2-mercapto-1-(beta-4-pyridethyl)benzimidazole. Biochim Biophys Acta (1969) 0.86
Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity. Leukemia (1995) 0.86
Inhibition of human immunodeficiency virus replication by the sulfonated stilbene dye resobene. Antiviral Res (1996) 0.86
[Collagenous colitis, IgA deficiency, Basedow's disease and atrophic gastritis]. Gastroenterol Clin Biol (1985) 0.85
Sulfonic acid dyes: inhibition of the human immunodeficiency virus and mechanism of action. J Acquir Immune Defic Syndr (1992) 0.85
Resistance to 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives is generated by mutations at multiple sites in the HIV-1 reverse transcriptase. Virology (1995) 0.85
The use of gallium scanning and determination of human chorionic gonadotropin to evaluate resorption of an abdominal placenta. Am J Obstet Gynecol (1983) 0.85
Reasoning about geography. J Exp Psychol Gen (2000) 0.84
Evidence for a DNA replicative genome for RNA-containing tumor viruses. Proc Natl Acad Sci U S A (1970) 0.84
Intranuclear degradation of the transformation-inducing protein encoded by avian MC29 virus. J Biol Chem (1986) 0.83
Metabolic requirements for infection by Rous sarcoma virus. II. The participation of cellular DNA. Virology (1966) 0.83
Virus-induced transformation without cell division. Science (1973) 0.83
Natural product-based anti-HIV drug discovery and development facilitated by the NCI developmental therapeutics program. J Nat Prod (2001) 0.83
[Rat bioassay with urine (PSU) for diagnosis and postoperative follow-up in Zollinger-Ellison syndrome (author's transl)]. Acta Gastroenterol Belg (1973) 0.81
Neural crest cells: temperature-dependent transformation by Rous sarcoma virus. Cell Differ (1979) 0.81
Flagellar surface differentiation. Evidence for multiple sites involved in mating of Chlamydomonas reinhardi. Exp Cell Res (1978) 0.80
A method for the propagation of large amounts of Rous sarcoma virus. Virology (1968) 0.80
Maternal herpes infection complicated by prolonged premature rupture of membranes. Am J Perinatol (1985) 0.79
Sodium concentrations affect metabolite uptake and cellular metabolism. J Cell Physiol (1978) 0.79
DNA sequence analysis of two bovine immunoglobulin CH gamma pseudogenes. J Immunogenet (1987) 0.79
Updating geographical knowledge: principles of coherence and inertia. J Exp Psychol Learn Mem Cogn (2000) 0.79
MC29 virus-coded protein occurs as monomers and dimers in transformed cells. J Virol (1985) 0.79
Uptake of exogenous metabolites by virus-transformed cells: changes induced by temperature and pH. Arch Biochem Biophys (1976) 0.78
Increased glucose uptake capacity of Rous-transformed cells and the relevance of deprivation derepression. Cancer Res (1981) 0.78
Mass screening for colorectal cancer: statement of the European Group for Colorectal Cancer Screening. Eur J Cancer Prev (1995) 0.78